Siheung-si, Gyeonggi-do, South Korea

Soon Ah Ahn

This inventor holds 1 USPTO granted patent. Top assignees: Hanmi Fine Chemical Co., Ltd., Hanmi Pharm. Co., Ltd.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Soon Ah Ahn

Introduction

Soon Ah Ahn is a notable inventor based in Siheung-si, Gyeonggi-do, South Korea. He has made significant contributions to the field of biochemistry, particularly through his innovative patent work. His expertise and dedication to research have led to advancements that benefit various industries.

Latest Patents

Soon Ah Ahn holds a patent for a "Polyethylene Glycol Derivative, Composition Comprising Same, and Method for Preparing Bioactive Polypeptide Conjugate by Using Same." This patent highlights his focus on developing biocompatible materials that can be utilized in medical and pharmaceutical applications. The innovation represented in this patent showcases his commitment to enhancing the effectiveness of bioactive compounds.

Career Highlights

Throughout his career, Soon Ah Ahn has worked with prominent companies such as Hanmi Fine Chemical Co., Ltd. and Hanmi Pharm. Co., Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to various projects that push the boundaries of scientific research.

Collaborations

Soon Ah Ahn has collaborated with talented individuals, including Yeon Jeong Jang and Yong Gyu Jung. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of innovative solutions.

Conclusion

Soon Ah Ahn's contributions to the field of biochemistry through his patent and collaborations demonstrate his significant impact on the industry. His work continues to inspire future innovations and advancements in science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…